ProductLife Group (PLG), a prominent global provider of consulting and outsourcing services for the life sciences sector, has announced the appointment of Dr. James Burt as its new Chief Executive Officer, effective March 2026. This strategic move marks a significant leadership transition aimed at bolstering the company's international presence and enhancing its service offerings across the pharmaceutical, biotechnology, and medical device industries.
Extensive Leadership Experience in Healthcare
Dr. Burt brings over two decades of international leadership experience, with a deep background spanning the entire pharmaceutical value chain. His expertise includes generics, biosimilars, orphan drugs, and value-added medicines, positioning him as a seasoned executive capable of navigating complex healthcare environments. His career is distinguished by a strong track record in scaling operations, driving strategic transformations, and leading global organizations to achieve substantial business growth.
Previous Roles and Achievements
Most recently, Dr. Burt served as Group CEO of Pharmanovia, where he spearheaded a major strategic overhaul that resulted in significant business expansion. Prior to that, he spent more than a decade at Accord Healthcare, culminating in his role as Executive Vice President for Europe, the Middle East, and Africa. In this capacity, he managed a profit and loss statement of approximately €750 million and oversaw a team of around 2,500 employees, demonstrating his adeptness at handling large-scale financial and operational responsibilities.
Educational Background and Industry Involvement
Dr. Burt holds a Ph.D. in Biochemical Engineering from the University of Birmingham, underscoring his academic credentials in a field critical to life sciences innovation. Additionally, he has held influential positions such as Vice President of Medicines for Europe and Chair of the Value-Added Medicines Group, further cementing his reputation as a key figure in the pharmaceutical industry.
Transition and Future Direction
This leadership change follows a period during which Shaun Chilton served as Executive Chairman, ensuring continuity and preparing PLG for its next developmental phase. Chilton will continue in his role as Chairman, working alongside Dr. Burt to guide the company forward. Dr. Burt's arrival is timed to coincide with PLG's ongoing efforts to expand its global footprint and strengthen capabilities in regulatory, clinical, quality, and digital services.
Strategic Vision for Growth
In a statement, Dr. Burt expressed enthusiasm about joining ProductLife Group, noting, "ProductLife Group has established itself as a trusted partner to the life sciences industry. I am excited to join the organization and work alongside its teams to further advance its capabilities and continue delivering value to clients and patients worldwide." This appointment signals a new era of growth for PLG as it aims to enhance its support for clients across the life sciences ecosystem, leveraging Dr. Burt's extensive experience to drive innovation and compliance.
About ProductLife Group
ProductLife Group is a global leader in providing end-to-end consulting and outsourcing services for the life sciences industry, assisting companies throughout the entire product lifecycle. With a presence in over 150 countries, operations in more than 50 nations, and a workforce exceeding 2,000 professionals, PLG supports a diverse range of clients in pharmaceuticals, biotechnology, medical devices, nutrition, and cosmetics. The company focuses on accelerating innovation, ensuring regulatory compliance, and improving patient outcomes worldwide.
